However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth ...

NEWCASTLE UPON TYNE, UK, 26 May 2022. QuantuMDx Group Limited (‘QuantuMDx’ or the ‘Company’), a UK-based developer of transformational point-of-care diagnostics, today announces the launch of its new ...

DUBLIN--(BUSINESS WIRE)--The "PCR For Respiratory Infection Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Multiplex PCR, Traditional PCR, Digital PCR, ...

Multiplexed SARS-CoV-2, Influenza A/B, and RSV and Poliovirus Typing Assays (1, 2 and 3) for the Bio-Rad, QIAGEN, and Thermo PCR Platforms FORT COLLINS, Colo., Dec. 20, 2022 /PRNewswire/ -- GT ...

MISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio ...

A new preprint describes a single-step molecular diagnostic test for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused by the Omicron variant that is behind ...

New multiplex panel can detect SARS-CoV-2, Flu A, Flu B & RSV at the Point of Need Accurate PCR results delivered in 35 minutes NEWCASTLE UPON TYNE, UK, 26 May 2022. QuantuMDx Group Limited ...

Specifically, Microbix is commercializing In-Vitro Diagnostic (“IVD”) quality controls to support workflow accuracy of “multiplex” clinical laboratory PCR tests that detect COVID, Flu A, Flu B, and ...